GlobalMed Virtual Care Platform Now Available in the Microsoft Azure Marketplace

SCOTTSDALE, Ariz., /PRNewswire/ -- GlobalMed, a Microsoft Gold partner and one of the first Federal Independent Software Vendors (ISV) for Microsoft, today announced the availability of its virtual care platform as a service, eNcounter®, in the Microsoft Azure Marketplace, an online store providing applications and services for use on Microsoft Azure. GlobalMed customers can now take advantage of the scalability, high availability, and security of Azure, with streamlined deployment and management.

GlobalMed became a leading Federal Independent Software Vendor (ISV) for Microsoft due to the unique capabilities of eNcounter, which is designed to unify vertically integrated hardware and software to simplify virtual care delivery for providers. In 2017, after a stringent process known as a Risk Management Framework, GlobalMed earned the much-coveted U.S. Department of Defense (DoD) Authority to Operate on DoD networks. The DoD selected GlobalMed for its HIPAA-compliant virtual care platform that seamlessly and securely connects healthcare professionals and patients, regardless of location.

GlobalMed’s eNcounter platform is optimally architected to maximize the configurability, reliability, and agility of Azure to drive accelerated application development and shape nascent virtual care business strategies for progressive healthcare delivery organizations.

In addition to security, the platform is designed for simplicity. Joel E. Barthelemy, founder and CEO of GlobalMed, said, “Our tools are simple, easy to learn, and never stand in the way of the patient-provider relationship. With eNcounter, our mobile and computer accessible software platform, clinicians can access robust care management features and practice management tools for any form of virtual care at any location.”

“Through Microsoft Azure Marketplace, customers around the world can easily find, buy, and deploy partner solutions they can trust, all certified and optimized to run on Azure,” said Sajan Parihar, Director, Microsoft Azure Platform at Microsoft Corp. “We’re happy to welcome GlobalMed’s eNcounter virtual care platform to the growing Azure Marketplace ecosystem.”

The Azure Marketplace is an online market for buying and selling finished Software as a Service (SaaS) applications and premium datasets. The Azure Marketplace helps connect companies seeking innovative, cloud-based solutions with partners who have developed solutions that are ready to use.

To learn more about eNcounter and schedule a demo, click here.

About GlobalMed
GlobalMed powers the world’s largest, most advanced virtual care programs and is honored to be the telehealth provider to the Department of Veterans Affairs, Defense Health Agency, and the White House. With over 15 million consults delivered in 55 countries, its virtual care platform has the Authority to Operate (ATO) on U.S. Department of Defense networks with the highest level of security and supports a patient at any point in the continuum of care. GlobalMed designs, manufactures, and deploys fully integrated software and hardware solutions that remove the barriers of technology from the business of patient care. Providers are enabled with data capturing tools to deliver evidence-based treatment and improve patient outcomes while lowering costs. Providers looking for their own technology to manage capacity, save money, and deliver responsible medicine, will get all they need from one platform. Recognizing the importance of trust and consistency in healthcare, GlobalMed also offers white-label versions of their systems so that providers can self-brand their virtual care offerings to strengthen the patient relationship with their organization. Learn more at www.globalmed.com.

Media contact:
Marcia Rhodes, Amendola Communications, 480-664-8412 ext. 15;
mrhodes@acmarketingpr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/globalmed-virtual-care-platform-now-available-in-the-microsoft-azure-marketplace-300788791.html

SOURCE GlobalMed